1. Home
  2. CHPT vs LNSR Comparison

CHPT vs LNSR Comparison

Compare CHPT & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChargePoint Holdings Inc.

CHPT

ChargePoint Holdings Inc.

HOLD

Current Price

$6.27

Market Cap

168.2M

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

SELL

Current Price

$5.66

Market Cap

146.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CHPT
LNSR
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Electronics
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.2M
146.7M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
CHPT
LNSR
Price
$6.27
$5.66
Analyst Decision
Hold
Strong Buy
Analyst Count
9
1
Target Price
$9.25
$10.00
AVG Volume (30 Days)
478.0K
67.2K
Earning Date
06-03-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$411,224,000.00
$58,435,000.00
Revenue This Year
$4.18
$10.06
Revenue Next Year
$16.63
$41.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.24
52 Week Low
$0.58
$5.06
52 Week High
$12.62
$13.74

Technical Indicators

Market Signals
Indicator
CHPT
LNSR
Relative Strength Index (RSI) 52.28 45.77
Support Level $5.60 $5.25
Resistance Level $6.73 $6.39
Average True Range (ATR) 0.33 0.33
MACD -0.07 0.15
Stochastic Oscillator 18.11 68.67

Price Performance

Historical Comparison
CHPT
LNSR

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.

Share on Social Networks: